Session-aware quotes · provider delays vary · Not financial advice
BullishMEDIUM severityMarkets10d ago

Valneva jumps as Lyme disease vaccine developed with Pfizer undergoes EU review

Reported by Seeking Alpha · seekingalpha.com · August 14, 2026

$PFE
Bullish read

Valneva (VALN) stock jumps as European regulator validates Pfizer (PFE)-partnered Lyme disease vaccine, PF-07307405. Read more here.

What the tape says

What to watch: Potential opportunity in Markets — evaluate fundamentals before acting.

Market reaction today: $PFE -0.36%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

More coverage on these names

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.